Sankey It
Loading...
Pfizer Inc. Q2 FY2025 income statement | Sankey It
Sankey It · PFE
Pfizer Inc. Q2 FY2025 income statement
USD · quarter ended 2025-06-29
Q2 FY2026
Q1 FY2026
Q4 FY2025
Q3 FY2025
Q2 FY2025
Quarterly
Annual
comfortable
compact
Hide amounts
Export
Fullscreen
Pfizer Inc. Q2 FY2025 income statement
Flow diagram with 8 nodes and 7 flows for Pfizer Inc. Q2 FY2025 income statement. Values: Revenue US$14.7B, Cost of Revenue US$5.2B, Gross Profit US$9.4B, Operating Expenses US$5.8B, Operating Income US$3.6B, Other Expense US$531M, Tax US$141M, Net Income US$2.9B.
Revenue
US$14.7B
Cost of Revenue
(US$5.2B)
36% of revenue
Gross Profit
US$9.4B
64% margin
Operating Expenses
(US$5.8B)
40% of revenue
Operating Income
US$3.6B
24% margin
Other Expense
(US$531M)
4% of revenue
Tax
(US$141M)
<1% of revenue
Net Income
US$2.9B
20% margin
Net / profit
Tax / cost
Copy link
Share on X
Open full screen